🔎 Trials Near Me

Akèy › Maladi fwa steatotik › Ohio › Dayton

Etid klinik pou Maladi fwa steatotik nan Dayton, OH

8 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Dayton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Dayton
  • 89bio Clinical Study Site, Dayton
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Dayton
  • 89bio Clinical Study Site, Dayton
  • 89bio Clinical Study Site, Springboro · 14 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Oct 5, 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Ap rekriteFaz 3
  • GSK Investigational Site, Springboro · 14 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT07704892

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Ap rekriteFaz 3
  • Dayton Gastroenterology - Beavercreek, Beavercreek · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Ap rekriteFaz 3
  • Akero Clinical Study Site, Springboro · 14 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Ap rekriteFaz 3
  • GSK Investigational Site, Springboro · 14 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT07221188

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Ap rekriteFaz 3
  • GSK Investigational Site, Springboro · 14 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Jul 27, 2026 · NCT07221227

Etid Maladi fwa steatotik nan lòt vil

Lòt etid nan Dayton

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.